Provexis Share Discussion Threads

[sleveen] 10/11/2017 17:19

INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2017
hxxps://doi.org/10.1080/09637486.2017.1376621

Not quite Lancet or NEJM standard.

[wheelds] 10/11/2017 17:07

Its worth pointing out that the share price keeps rising and on some sites the bid price is stated as 0.7p.
I am looking forward to see what the share price and bid price starts up on Monday.
But because we only have good news to come, in my opinion, the share price should now keep rising relative to potential and actual increased revenues.IMHO

[librag] 10/11/2017 11:09

sleveen;
Lazy me ... found it myself.
"Capsules were coded in accordance with a randomisation protocol.
All supplements were identical with respect to appearance
and only differed in coding of the capsules. The
treatment code of the intervention supplements was
blinded for subjects, investigators and staff involved in
the conduct of the study."

Doesn't actually say how the codes were obtained but usually it's a RND function.

addendum.
The authors give no figures for pre study BP but the diagrams do look like the FF group has a lower BP to begin with, although not noted on the diagrams and apparently not statistically significant. Maybe there no difference, maybe there is and not seen due to the very small sample size, maybe RND was suspect? Maybe, maybe not, I'm afraid.

It's worth pointing out that the subjects were NOT hypertensive. Wittering on the blue channel about anti-hypertensive drugs on the basis of this study is very silly.

[librag] 10/11/2017 11:05

You look fit ... have a capsule.
Don't read any long books ... placebo group for you.

Only joking. :)

I haven't kept the link but if you paste it, I'd be interested to check it out although I'm not sure publications usually describe the method?

[sleveen] 10/11/2017 10:50

Those bp reduction are certainly impressive.

However I would like to see the randomization methodology.

[librag] 09/11/2017 18:29

:) Congratulations. For your next lesson, run a spell check.

[wheelds] 09/11/2017 17:43

ShArE PrICe UP 10% OR oNE TenTh today, and bid price up to 0.5p; so the ups and downs and the caps and locks with our share price is now free to go.IMHO
All looking good as we move towards December results and getting news from China, and news of further increases in revenue.

And today further good news of improved relationship growing between China and America which can only be a good thing for Provexis and our partner DSM once By-Health, in colaboration with Provexis starts producing Fruitflow products in China.IMHO

[librag] 09/11/2017 11:29

I wonder if the idiot knows what Caps Lock does?

[wheelds] 08/11/2017 23:59

aLL ABOUT HOW FRUITFLOW LOWERS BLOOD PRESSURE:, BY DOCTOR SARAH BREWER:-

[wheelds] 08/11/2017 18:46

SIRCO, OUR FRUITFLOW REFRESSHING DRINK IN DM STORES IN GERMANY

[lafin] 01/11/2017 08:09

Oh no-look what it says on Moneyweek

"It's time to reinvent the stockmarket"

[librag] 31/10/2017 17:41

lafin; try not to be a prat all your life.

[lafin] 31/10/2017 11:08

^^^^^^^ seems to forget he is typing on a share board at times and has no more authority than anyone else.


Of course you may have forgotten.

[librag] 30/10/2017 12:34

Aaaaaaaargh!
Your quote is the TITLE, not its conclusion. There is NO evidence of improvement in memory after treatment with Fruitflow-II.

As I said, the trial died a death.

Your second para. ...
"Note the bit about Blood Flow and high blood pressure, and we have only just finished and reported our latest trials on how Fruitflow can lower blood pressure; and improved blood flow by using Fruitflow has been passed by the EFSA 13.5 So, im my opinion ... "

YOU GOOGLE SOMETHING, SEE IT MENTION SOMETHING ELSE AND "IN YOUR OPINION", RELATE THE TWO. The trouble is, unless you're a science graduate or unusually perceptive, your opinion is worthless and invariably wrong.

I actually agree with Peppa (this time at least) ... you, and others, need to listen more and recognise when you're out of your depth. Asking questions, rather than giving your opinion will be a good start. Sorry.

[wheelds] 30/10/2017 01:46

"In fact high BP is responsible for 80% of all heart attacks and stroke. Increased blood pressure weakens the small vessels in the brain causing them to rupture. Interruption of blood flow to the brain may also increase the risk of mild cognitive impairment and dementia."

Note the bit about Blood Flow and high blood pressure, and we have only just finished and reported our latest trials on how Fruitflow can lower blood pressure; and improved blood flow by using Fruitflow has been passed by the EFSA 13.5
So, im my opinion the benefits of Fruitflow and the many trials with positive results are all coming together and looking good for the partnership between Provexis and the global DSM and the 3 billion pound Chinese company By-Health.
Should get some more good news this December. IMHO

[wheelds] 30/10/2017 01:28

Exactly my point; Still no details of the trials other then,-

"Evidence of improvement in memory after treatment with Fruitflow-II,"

Hoping for further update on the benefits of Fruitflow on people suffering from cognitive health problems.
An awful lot of interest today in the why of memory loss, and up and down the country today health organisations like the Alzheimer's group are setting up what they call memory clubs and generally are encouraged to do more physical exercise and play table table tennis and indoor bowling to encourage hand and eye coordination.
Hence, today there is a growing concern about the millions who are getting diagnosed with Alzheimer's and Dementia other cognitive health problems.

So, here's hoping for good news about the benefits of using Fruitflow from the trials, as it is well over due.

[wheelds] 29/10/2017 01:06

It seems the trial started in 2015!

Drug: Fruitflow-II
Drug: resVida
Primary Outcome(s)
"Evidence of improvement in memory after treatment with Fruitflow-II, resVida (Resveratrol), alone or in combination [Time Frame: 3 months]"


ALL ABOUT COGNITIVE HEALTH AND THE BENEFITS OF FRUITFLOW:-

"Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II)"

[librag] 27/10/2017 14:35

Gixer, I agree re. the DVT study. The mechanism of clot formation is different with venous thrombosis. Essentially it is more flow dependent and more likely to respond to FF. This, despite the fact that arterial thrombosis is highly platelet dependent ... it’s complicated.

Would you please inform the iii poster of our discussion, he needs to know. Positive re. chance of effect re. DVT and negative re. dementia.

GL

[gix er] 27/10/2017 13:39

LibraG, "FF doesn’t reduce clotting so it’s irrelevant in this case."

Maybe but if I am correct it reduces the risk of a clot forming in the first place.
The upcoming planned DVT study might shed some light on this?